Vertex Pharmaceuticals Inc. buy EPG2026
Start price
27.01.13
/
50%
€34.73
Target price
19.04.13
€40.00
Performance (%)
85.13%
End price
19.04.13
€64.30
Summary
This prediction ended on 19.04.13 with a price of €64.30. With a performance of 85.13% the BUY prediction by EPG2026 was a big success. EPG2026 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 5.532% | 5.532% | 7.571% | 29.311% |
| iShares Core DAX® | 0.563% | 0.440% | 5.873% | 54.931% |
| iShares Nasdaq 100 | -0.162% | 1.619% | 37.058% | 90.559% |
| iShares Nikkei 225® | 1.098% | 9.607% | 65.636% | 80.263% |
| iShares S&P 500 | 0.014% | 0.689% | 25.677% | 67.607% |
Comments by EPG2026 for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Sehr gute Biotechaktie
Vertex Pharma hat gute Produkte in der Pipeline
(Vom Mitglied beendet)

